MeSH term | MeSH ID | Detail |
---|---|---|
Otitis Media | D010033 | 12 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
MeSH term | MeSH ID | Detail |
---|---|---|
Otitis Media | D010033 | 12 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Hosaka S et al. | In vivo evaluation of ocular inserts of hydrogel impregnated with antibiotics for trachoma therapy. | 1983 | Biomaterials | pmid:6640048 |
Inman WH and Rawson NS | Erythromycin estolate and jaundice. | 1983 | Br Med J (Clin Res Ed) | pmid:6407653 |
Ozawa H et al. | Ocular inserts for controlled release of antibiotics. | 1983 | Biomaterials | pmid:6615978 |
Ginsburg CM et al. | Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate. | 1982 Nov-Dec | Pediatr Infect Dis | pmid:6761656 |
Simmen HP et al. | [Erythromycin]. | 1982 | Dtsch. Med. Wochenschr. | pmid:7117164 |
Trujillo H | Cefadroxil monohydrate versus erythromycin in paediatric patients. | 1981 | J. Int. Med. Res. | pmid:7227625 |
Patamasucon P et al. | Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. | 1981 | Antimicrob. Agents Chemother. | pmid:6975059 |
Selenke WM et al. | Nonantibiotic effects of macrolide antibiotics of the oleandomycin-erythromycin group with special reference to their "steroid-sparing" effects. | 1980 | J. Allergy Clin. Immunol. | pmid:6966289 |
Henry J et al. | Plasma and salivary concentrations of erythromycin after administration of three different formulations. | 1980 | Postgrad Med J | pmid:7220406 |
DiSanto AR et al. | Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets. | 1980 | J Clin Pharmacol | pmid:7430412 |
Dujovne CA and Salhab AS | Erythromycin estolate vs. erythromycin base, surface excess properties and surface scanning changes in isolated liver cell systems. | 1980 | Pharmacology | pmid:7403251 |
Abernathy CO et al. | Cytotoxic effects of erythromycin estolate and chlorpromazine on hepatocytes isolated from rats of varying ages: a brief note. | 1980 | Mech. Ageing Dev. | pmid:7354660 |
Pessayre D and Benhamou JP | Hepatotoxicity of erythromycin derivatives. | 1979 | Br Med J | pmid:445081 |
Drew R and Piestly BG | Effect of chlorpromazine and erythromycin on bile salt-induced cholestasis in the rat. | 1979 | Pharmacology | pmid:572556 |
Welling PG et al. | Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate. | 1979 | J Pharm Sci | pmid:423080 |
Krowchuk D and Seashore JH | Complete biliary obstruction due to erythromycin estolate administration in an infant. | 1979 | Pediatrics | pmid:514726 |
Chen KC et al. | Amine content of vaginal fluid from untreated and treated patients with nonspecific vaginitis. | 1979 | J. Clin. Invest. | pmid:447831 |
Cooksley WG and Powell LW | Erythromycin jaundice: diagnosis by an in vitro challenge test. | 1977 | Aust N Z J Med | pmid:269690 |
McCormack WM et al. | Hepatotoxicity of erythromycin estolate during pregnancy. | 1977 | Antimicrob. Agents Chemother. | pmid:21610 |
Brown ST et al. | Comparison of erythromycin base and estolate in gonococcal urethritis. | 1977 | JAMA | pmid:408522 |